COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference
14/02/2018
SAN CARLOS, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Poseida Therapeutics Presents Stem Cell Memory CAR-T Therapy for Prostate Cancer at 2018 Keystone Symposia on Emerging Cellular Therapies
14/02/2018
SAN DIEGO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, presented preclinical [...]
Tauriga Sciences, Inc. Fully Repays $27,500 Face Value 8.00% Convertible Debenture Issued to Adar Bays, LLC for One Time Cash Payment of $39,312.78
14/02/2018
New York, NY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK Current Tier: TAUG) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of [...]
Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference
14/02/2018
WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that Jesper Høiland, President and CEO of the Company, will present a corporate update at the 2018 RBC Capital [...]
Radius Health to Announce Fourth Quarter and Full Year 2017 Financial Results, Host Conference Call and Live Webcast on March 1, 2018
14/02/2018
WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that it will release its fourth quarter and full year 2017 financial results on Thursday, March 1, 2018. The Company [...]
Dynavax to Present at the RBC Capital Markets Global Healthcare Conference
14/02/2018
BERKELEY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s chief executive officer, will participate in a fireside chat at the 2018 [...]
Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis
14/02/2018
BUFFALO, N.Y., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer
14/02/2018
RA’ANANA, Israel and NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Sona Jasani, MD is Honored by the American Health Council for “Best in Medicine”
14/02/2018
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Sona Jasani, MD as one of “America’s Best Doctors” for her unparalleled professional dedication and extraordinary contributions [...]
HempAmericana Fully Executes Contract To Acquire Local Farm for Seed Production
14/02/2018
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the potential acquisition of a ten acres farm in Maine. The Company [...]
Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures
14/02/2018
DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded U.S. Food and [...]
Inovalon Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
14/02/2018
BOWIE, Md., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Alimera Sciences to Report Fourth Quarter and Full Year 2017 Results on February 28, 2018
14/02/2018
ATLANTA, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ: ALIM ), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its [...]
Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results and Provides Business Update
14/02/2018
Worldwide Net Ocaliva ® (obeticholic acid or OCA) full year 2017 net sales of $129.2 million, fourth quarter 2017 sales of $37.3 million U.S. Prescribing Information for Ocaliva ® updated to reinforce appropriate dosing [...]
Shire plc : Final Results
14/02/2018
Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017 Strong growth driven by Immunology, recently launched products, and global expansion [...]
Agios Reports Fourth Quarter and Full Year 2017 Financial Results
14/02/2018
– All 2017 Key Milestones Achieved, Including First U.S. Product Approval from Agios’ Discovery Platform and NDA Submission for Second Product Candidate, Ivosidenib, for IDH1m R/R AML – – 2018 Priorities Focus on [...]
Midatech Pharma Plc: Trading update
14/02/2018
14 February 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Trading update Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising [...]
AxoGen, Inc. to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018
14/02/2018
ALACHUA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve injuries, today announced that [...]
G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018
14/02/2018
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that fourth quarter and full-year 2017 financial results will be [...]

Pages